Al-Razi Medical Company (TADAWUL:9572)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
32.68
+1.34 (4.28%)
At close: Dec 4, 2025

Al-Razi Medical Company Ratios and Metrics

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
509091--
Market Cap Growth
-34.64%-1.34%---
Enterprise Value
629897--
Last Close Price
32.6859.0059.80--
PE Ratio
176.33509.93132.51--
PS Ratio
0.771.461.48--
PB Ratio
2.183.964.06--
P/TBV Ratio
2.214.034.15--
P/FCF Ratio
61.1581.5591.19--
P/OCF Ratio
12.6318.0915.73--
EV/Sales Ratio
0.971.601.59--
EV/EBITDA Ratio
12.2036.6232.66--
EV/EBIT Ratio
44.1594.3562.66--
EV/FCF Ratio
76.8989.3197.71--
Debt / Equity Ratio
0.580.380.480.320.27
Debt / EBITDA Ratio
2.561.782.041.451.49
Debt / FCF Ratio
16.117.8610.73--
Asset Turnover
1.341.421.391.26-
Inventory Turnover
2.212.231.981.84-
Quick Ratio
0.290.270.140.190.89
Current Ratio
1.561.921.792.072.61
Return on Equity (ROE)
1.25%0.78%2.99%8.43%-
Return on Assets (ROA)
1.85%1.51%2.20%3.88%-
Return on Capital (ROIC)
2.62%2.02%3.02%5.19%-
Return on Capital Employed (ROCE)
4.20%3.50%5.00%8.60%8.20%
Earnings Yield
0.57%0.20%0.76%--
FCF Yield
1.64%1.23%1.10%--
Dividend Yield
4.86%-2.65%--
Payout Ratio
--351.72%93.81%-
Total Shareholder Return
4.86%-2.65%--
Source: S&P Capital IQ. Standard template. Financial Sources.